Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Surg Neurol ; 64(2): 116-20; discussion 121, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16051000

ABSTRACT

BACKGROUND: Intradural arteries formerly in vasospasm after subarachnoid hemorrhage (SAH) show structural changes that result in arterial wall thickening and luminal narrowing. To evaluate if these changes lead to maldistribution of cerebral perfusion and reduced cerebrovascular reserve capacity (CVRC) in surviving patients, a long-term follow-up study of 18 adult patients after SAH was performed. METHODS: Eighteen patients were selected for the study, all had shown vasospasm after an early operation on a ruptured aneurysm, were in good neurological condition (GOS [Glasgow Outcome Score] 4 or 5 ), and had no residual infarcts. A technetium-99m-hexamethyl-propylenamine oxime (HMPAO) single-photon emission computed tomography was performed 15 to 73 months after SAH. To study CVRC, a second investigation after application of acetazolamide was performed 1 week later. RESULTS: Single-photon emission computed tomography showed areas of focally reduced HMPAO uptake predominantly in the hemisphere ipsilateral to the vessels more affected by posthemorrhagic vasospasm. The thalamus and the basal ganglia, the frontal lobe, and the temporal lobe were the regions most frequently showing reduced uptake. The individual change of HMPAO uptake after acetazolamide application ranged from -7% to 44% (mean, 17% +/- 15%). CONCLUSIONS: These results show a remarkable reduction of CVRC compared with findings in healthy individuals. Based on these new findings, further investigations focusing on CVRC in routine SAH follow-up are worth being considered.


Subject(s)
Subarachnoid Hemorrhage/complications , Subarachnoid Hemorrhage/pathology , Vasospasm, Intracranial/etiology , Vasospasm, Intracranial/pathology , Adult , Female , Follow-Up Studies , Humans , Male , Middle Aged , Oximes , Regional Blood Flow , Subarachnoid Hemorrhage/diagnostic imaging , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed
2.
Epilepsia ; 44(4): 582-90, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12681009

ABSTRACT

PURPOSE: Postictal psychosis is a well-known complication, occurring especially in patients with temporal lobe epilepsy. It usually runs a benign course. The literature on this topic is sparse, and the underlying pathogenic mechanisms are not known. METHODS: We report five patients with temporal lobe epilepsy in whom postictal psychosis developed during the course of video-EEG monitoring; they were studied with hexamethyl-propyleneamine-oxime single-photon emission computed tomography (HMPAO-SPECT) during and after the psychotic event. RESULTS: In comparison to the interictal state, all SPECT scans obtained during postictal psychosis were remarkable for bifrontal and bitemporal hyperperfusion patterns. Some studies also demonstrated unilateral left lateral frontal hyperperfusion. These cortical blood-flow patterns appeared to be distinct from those obtained during complex partial seizures. CONCLUSIONS: Our data suggest that postictal psychoses in patients with temporal lobe epilepsy are associated with hyperactivation of both temporal and frontal lobe structures. This hyperperfusion may reflect ongoing (subcortical) discharges, active inhibitory mechanisms that terminate the seizure, or simply a dysregulation of cerebral blood flow.


Subject(s)
Epilepsy, Complex Partial/diagnostic imaging , Epilepsy, Temporal Lobe/diagnostic imaging , Neurocognitive Disorders/diagnostic imaging , Tomography, Emission-Computed, Single-Photon , Adult , Dominance, Cerebral/physiology , Electroencephalography , Epilepsy, Complex Partial/physiopathology , Epilepsy, Temporal Lobe/physiopathology , Female , Frontal Lobe/blood supply , Frontal Lobe/diagnostic imaging , Humans , Hyperemia/diagnostic imaging , Hyperemia/physiopathology , Male , Monitoring, Physiologic , Neurocognitive Disorders/physiopathology , Risk Factors , Technetium Tc 99m Exametazime , Temporal Lobe/blood supply , Temporal Lobe/diagnostic imaging , Video Recording
3.
World J Biol Psychiatry ; 3(3): 133-46, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12478878

ABSTRACT

Considerable progress has been achieved over the past 15 years in uncovering the biological basis of major psychiatric disorders. To determine patterns of brain dysfunction and to uncover the mechanism of action of centrally active compounds we used single photon emission computerized tomography (SPECT) as well as positron emission tomography (PET) in patients diagnosed with schizophrenia, depression, bulimia and Tourette's disorder. Striatal D2 and 5-HT1A receptors were studied in schizophrenia and 5-HT transporters (5-HTT) in depression and bulimia. Patients were either drug-naïve or drug free, or we studied the influence of specifically acting compounds on receptor/transporter occupancy. We could demonstrate that atypical antipsychotics have a dose-dependent (with the exception of clozapine and quetiapine) lower striatal D2 receptor occupancy rate compared with typical neuroleptics, paralleling the more favourable extrapyramidal side effects of atypical antipsychotics. However, no association between striatal D2 receptor occupancy rates and antipsychotic efficacy has been found. The measurement of 5-HT1A receptors in drug-naïve schizophrenic patients using the in vivo PET methodology revealed an increase of cortical 5-HT1A receptor binding potential in schizophrenia. beta-CIT as a ligand for measurement of 5-HT transporter densities (5-HTT) revealed lower rates in depression compared to age- and sex-matching healthy controls, a measurement that has also been obtained for bulimia. We also documented seasonal variations in brain serotonergic function by our finding of reduced brain 5-HTT availability in winter (compared to summer) in healthy controls. Furthermore, displaceable [123I] beta-CIT binding in the area corresponding to the left striatum (representing predominantly the density of dopamine transporters) was significantly reduced in SAD patients compared to healthy controls. In depression as well as in bulimia, selective serotonin reuptake inhibitors significantly decreased the beta-CIT binding potential, however, no significant dose relationship has been obtained in depression. Genotyping depressed patients for the serotonin transporter promoter gene region (5-HTTLPR) did not provide evidence for in vivo functional regulation of 5-HTT availability by 5-HTTLPR in the thalamus-hypothalamus and mesencephalon-pons of healthy subjects. In patients suffering from Tourette's disorder (TD) we were unable to detect differences of dopamine transporter densities between psychotropic drug-naïve TD patients and controls. Furthermore, no difference could be found between currently treated (with antipsychotics) and psychotropic drug-naïve TD patients. Our data provide insight into the pathophysiology of neuropsychiatric disorders and may guide future psychopharmacological drug developments.


Subject(s)
Antidepressive Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Brain/metabolism , Bulimia , Bulimia/metabolism , Carrier Proteins/metabolism , Depressive Disorder, Major , Membrane Glycoproteins/metabolism , Membrane Transport Proteins/metabolism , Nerve Tissue Proteins , Receptors, Dopamine/metabolism , Receptors, Serotonin/metabolism , Schizophrenia , Tourette Syndrome , Bulimia/drug therapy , Bulimia/genetics , Corpus Striatum/metabolism , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/genetics , Depressive Disorder, Major/metabolism , Dopamine Plasma Membrane Transport Proteins , Humans , Promoter Regions, Genetic/genetics , Schizophrenia/diagnostic imaging , Schizophrenia/drug therapy , Schizophrenia/genetics , Seasons , Serotonin Plasma Membrane Transport Proteins , Tomography, Emission-Computed , Tomography, Emission-Computed, Single-Photon , Tourette Syndrome/drug therapy , Tourette Syndrome/genetics , Tourette Syndrome/metabolism
4.
Neuropsychobiology ; 45(2): 67-73, 2002.
Article in English | MEDLINE | ID: mdl-11893862

ABSTRACT

Changes in regional cerebral blood flow (rCBF) due to long-term abuse of opioids such as heroin or morphine are not yet fully understood in humans. The goal of the present study was to investigate rCBF alterations in a large sample of long-term opioid addicts in comparison to healthy controls. We investigated 21 opioid-dependent subjects, who were currently abusing heroin or were enrolled in a methadone or morphine maintenance program, and 36 healthy controls with (99m)Tc-HMPAO single photon emission computed tomography. We found a decrease in rCBF in most regions of interest in patients in comparison to controls. Long-term opioid dependence seems to decrease prefrontal CBF in particular. A right-greater-than-left CBF asymmetry in healthy subjects was reversed in patients. This change in CBF symmetry could reflect the different emotional status of opioid-dependent patients. Our findings are in line with neuropsychological investigations indicating a correlation of mood states with lateralization of hemispheric activation patterns.


Subject(s)
Cerebrovascular Circulation/drug effects , Opioid-Related Disorders/physiopathology , Adult , Case-Control Studies , Female , Functional Laterality , Heroin Dependence/physiopathology , Humans , Male , Methadone/administration & dosage , Morphine Dependence/physiopathology , Opioid-Related Disorders/diagnostic imaging , Prefrontal Cortex/blood supply , Tomography, Emission-Computed, Single-Photon
SELECTION OF CITATIONS
SEARCH DETAIL
...